Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Intellipharmaceutics International Inc.

TRADE

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
0.61-0.03-4.69%Vol 303 6861Y Perf -94.08%
Oct 16th, 2018 16:00
BID0.61 ASK0.64
Open0.65 Previous Close0.64
Pre-Market0.63 After-Trading0.61
 -0.01 -1.56%  - -%
Target Price
27.50 
Analyst Rating
Moderate Buy 1.67
Potencial %
4 408.20 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     45.18
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)3 
Earnings Rating
Price Range Ratio 52wk %
0.20 
Earnings Date

Today's Price Range

0.590.65

 

52wk Range

0.5910.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-77.66%
3 Months
35.56%
6 Months
17.31%
1 Year
-94.08%
3 Years
-67.55%
5 Years
-69.95%

Quotes

Name / TickerPriceChg.Chg.%
IPCI0.61-0.0300-4.69
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.50
Current Ratio 0.60
Long Term Debt to Total Capital -
Total Debt to Equity 3.34
Interest Coverage -25.50
Leverage Ratio -5.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin82.40
EBIT Margin-335.10
EBITDA Margin-315.60
Pre-tax Profit Margin-318.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 62.79
PS Ratios 1.01
Price to Cash Flow -
Price to Free Cash Flow -0.40
Cash Flow Per Share -3.18
Price to Tangible Book-2.68
Book Value per Share-0.24
Enterprise Value (in ths.)3 037
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)123 469.00
ROE last 12 Months 11 611.40
Return on Assets (5Y Avg) -112.90
ROA last 12 Months -149.89
Return on Capital (5Y Avg) -
ROC last 12 Months -189.03
Return on invested Capital Q -189.03
Return on invested Capital Y-387.94
Assets Turnover0.30
Receivables Turnover1.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 989
Revenue per Share 0.63
Revenue Growth 3 Years -9.00
Revenue Growth 5 Years 107.70
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Q03 2016-0.07-0.070.00
Earnings Per EndEstimateRevision %Trend
8/2018 QR-0.400.00-
11/2018 QR0.00--
11/2018 FY-1.950.00-
11/2019 FY-1.000.00-
Next Report Date16th Oct 2018
Estimated EPS Next Report-0.40
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume303 686
Shares Outstanding (in ths.)4 350
Trades Count639
Dollar Volume148 244
Avg. Volume81 799
Avg. Weekly Volume1 980 270
Avg. Monthly Volume560 613
Avg. Quarterly Volume188 935

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x